Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
METAFOR delayed-release metformin study in gestational diabetes
ISRCTN90686599Phase 2Completed
- Sponsor
- University of Edinburgh
- Start
- Sep 2023
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, open-label trial of metformin in gestational diabetes mellitus (GDM) (3 arms), sponsored by University of Edinburgh. Primary endpoint: Maternal:fetal serum metformin ratio at delivery. Started Sep 2023; status: completed.
02
Drugs
metformin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on ISRCTN90686599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN90686599.